PD-1 and PD-L1: architects of immune symphony and immunotherapy breakthroughs in cancer treatment

Overview of attention for article published in Frontiers in immunology, December 2023

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (91st percentile)
High Attention Score compared to outputs of the same age and source (97th percentile)

So far, Altmetric has seen 28 X posts from 28 X users, with an upper bound of 102,762 followers.

RT @FrontImmunol: New Research: PD-1 and PD-L1: architects of immune symphony and immunotherapy breakthroughs in cancer treatment: PD-1 (Pr…

RT @FrontImmunol: New Research: PD-1 and PD-L1: architects of immune symphony and immunotherapy breakthroughs in cancer treatment: PD-1 (Pr…

RT @Amirbio2: لذت ببرید از خواندن‌ش گویی اینکه به سمفونی مورد علاقه‌تون گوش کردید در آخر هم یه سلامی عرض کنید به خدمت تمام رذل‌هایی که "تحر…

RT @FrontImmunol: New Research: PD-1 and PD-L1: architects of immune symphony and immunotherapy breakthroughs in cancer treatment: PD-1 (Pr…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 24 additional X posts.